Mounjaro vs Wegovy UK - Compare Prices & Which Is Better

Clinically Proven UK Registered Pharmacy

Mounjaro vs Wegovy - Compare Cheapest UK Prices

Compare Mounjaro vs Wegovy at the cheapest UK prices from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro vs Wegovy: Which Weight Loss Injection Works Best for UK Patients?

When comparing Mounjaro vs Wegovy, UK patients often ask which injectable weight loss treatment delivers better results. Both medications are highly effective GLP-1 receptor agonists licensed by the MHRA for chronic weight management, but they work through different mechanisms and show distinct efficacy profiles in clinical trials. As a UK-registered pharmacy with thousands of weight loss consultations completed, we've seen both treatments transform patient outcomes when prescribed appropriately.

Key Differences Between Mounjaro vs Wegovy for Weight Loss

The fundamental difference in the Mounjaro vs Wegovy debate lies in their active ingredients and receptor mechanisms. Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist, whilst Wegovy contains semaglutide, a selective GLP-1 receptor agonist [1]. This dual-action mechanism means Mounjaro targets two incretin pathways simultaneously, potentially offering enhanced metabolic benefits beyond weight reduction alone.

Clinical trial data demonstrates that Mounjaro users achieved average weight loss of 15-22.5% of initial body weight across the SURPASS clinical programme, compared to Wegovy's 10.9-15% average weight reduction in the STEP trials [2]. Both medications work by reducing appetite, slowing gastric emptying, and improving insulin sensitivity, but the additional GIP receptor activation in Mounjaro may explain its superior weight loss outcomes in head-to-head comparisons. All prescription treatments require clinical assessment by a UK-registered prescriber before dispensing.

Mounjaro vs Wegovy: Clinical Trial Evidence and Efficacy

When evaluating Mounjaro vs Wegovy through rigorous clinical evidence, the SURPASS-2 trial provides direct comparative data. Participants taking tirzepatide 15mg lost an average of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks [3]. The STEP 1 trial showed Wegovy users achieved mean weight loss of 14.9% at 68 weeks, whilst SURPASS-1 demonstrated Mounjaro users lost up to 22.5% at the highest 15mg dose [4].

Both treatments show sustained efficacy when combined with lifestyle modifications including a reduced-calorie diet and increased physical activity. In our clinical experience across thousands of UK consultations, patients on either medication report significant appetite suppression within the first fortnight of treatment. The choice between Mounjaro vs Wegovy often depends on individual response, tolerability, and the degree of weight loss required to achieve health goals.

Real-World Effectiveness in UK Patients

Beyond controlled trials, real-world evidence from UK prescribing data suggests both Mounjaro and Wegovy deliver clinically meaningful weight loss when prescribed appropriately. Our superintendent pharmacist Tarun Kumar notes that patient adherence remains the strongest predictor of success with either treatment, with weekly injection routines proving manageable for most individuals. Subject to prescriber approval, both medications can be continued long-term for weight maintenance after initial reduction phases.

Side Effects: Mounjaro vs Wegovy Safety Profiles

The side effect profiles when comparing Mounjaro vs Wegovy show considerable overlap, as both are incretin-based therapies. The most common adverse effects include nausea (reported in 20-44% of users), diarrhoea, constipation, vomiting, and abdominal discomfort [5]. These gastrointestinal symptoms typically occur during dose escalation phases and diminish over 4-8 weeks as tolerance develops.

Mounjaro users report slightly higher rates of nausea at equivalent weight loss levels compared to Wegovy, likely due to its dual receptor mechanism producing more pronounced effects on gastric motility. However, serious adverse events remain rare with both treatments. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. All patients require baseline assessment and ongoing monitoring by UK healthcare professionals.

Managing Common Side Effects

In our experience supporting UK patients through Mounjaro vs Wegovy treatment journeys, simple strategies significantly reduce side effect burden. Taking injections after meals rather than on an empty stomach, staying well-hydrated, eating smaller frequent meals, and avoiding high-fat foods all improve tolerability. Most patients find symptoms manageable and consider them acceptable trade-offs for the weight loss achieved.

Feature Mounjaro Wegovy
Active Ingredient Tirzepatide Semaglutide
Receptor Mechanism Dual GIP/GLP-1 GLP-1 only
Average Weight Loss 15-22.5% 10.9-15%
Starting Dose 2.5mg weekly 0.25mg weekly
Maximum Dose 15mg weekly 2.4mg weekly
Injection Frequency Once weekly Once weekly
Common Side Effects Nausea, diarrhoea, vomiting Nausea, diarrhoea, constipation
UK Price (Cured Pharmacy) From £145.00 From £89.00
MHRA Licensed Yes Yes
Prescription Required Yes Yes

Dosing Schedules: Mounjaro vs Wegovy Administration

Both Mounjaro vs Wegovy require once-weekly subcutaneous injections, typically administered in the abdomen, thigh, or upper arm. Wegovy follows a fixed escalation schedule starting at 0.25mg weekly, increasing monthly to a maintenance dose of 2.4mg [6]. Mounjaro begins at 2.5mg weekly and can be titrated up to 15mg based on individual response and tolerability, offering more flexible dosing options.

The injection devices differ slightly: Mounjaro uses a KwikPen auto-injector whilst Wegovy employs a pre-filled FlexTouch pen. Both systems are designed for home self-administration after initial training. Patients should rotate injection sites weekly and maintain consistent injection timing for optimal therapeutic levels. Missing occasional doses is generally well-tolerated, but consistency improves outcomes.

Cost Comparison: Mounjaro vs Wegovy UK Pricing

When evaluating Mounjaro vs Wegovy from a cost perspective, UK pricing varies significantly by dose and supplier. At Cured Pharmacy, Wegovy starts from £124.99 whilst Mounjaro begins at £124.99, both subject to clinical assessment and prescriber approval. New patients can access £20 off their first order using code Weightlossnew, making treatment more accessible for those beginning their weight loss journey.

The price difference reflects Mounjaro's newer market entry and dual-receptor formulation, though both represent considerable monthly investments. Many patients find the superior weight loss outcomes with Mounjaro justify the additional cost, whilst others achieve their goals successfully with Wegovy at a lower price point. Neither medication is routinely available on NHS prescription for weight management alone, making private online pharmacies like Cured Pharmacy the primary access route for most UK patients. All pricing is transparent and displayed before consultation, with no hidden fees.

Long-Term Treatment Costs

When comparing Mounjaro vs Wegovy over extended treatment periods, patients should budget for 6-12 months of therapy to achieve and consolidate weight loss goals. Maintenance doses can sometimes be reduced after initial weight reduction, potentially lowering ongoing costs. Our clinical team provides personalised guidance on optimal treatment duration during online consultations.

Which Should You Choose: Mounjaro vs Wegovy Decision Guide

Deciding between Mounjaro vs Wegovy depends on multiple individual factors including weight loss goals, budget, previous treatment response, and medical history. Patients requiring greater weight reduction (>20% body weight) may benefit more from Mounjaro's enhanced efficacy, whilst those seeking effective results at lower cost often succeed with Wegovy. Both medications require commitment to lifestyle changes for optimal outcomes.

During your free online consultation at Cured Pharmacy, our UK-registered prescribers assess your BMI, weight loss history, comorbidities, current medications, and personal preferences to recommend the most appropriate option. The consultation takes under 3 minutes to complete, and approved prescriptions are dispensed from our UK-registered pharmacy with discreet next-day delivery. Both Mounjaro and Wegovy represent evidence-based, MHRA-licensed treatments that have helped thousands of UK patients achieve sustainable weight loss when used as part of comprehensive weight management programmes [7].

Scientific References

  1. Frías, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Frías, J. P., et al. (2021). Efficacy and safety of tirzepatide versus semaglutide: SURPASS-2 trial results. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  4. Wilding, J. P., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  5. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro and Wegovy: Summary of Product Characteristics. MHRA UK. [accessed 15 August 2026]
  6. Electronic Medicines Compendium. (2023). Wegovy 2.4mg solution for injection in pre-filled pen. Datapharm Ltd. [accessed 15 August 2026]
  7. National Institute for Health and Care Excellence. (2023). Semaglutide and tirzepatide for managing overweight and obesity. NICE guideline TA875. [accessed 15 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mounjaro or Wegovy better for weight loss?
Clinical trials show Mounjaro (tirzepatide) delivers greater average weight loss of 15-22.5% compared to Wegovy's 10.9-15%, though both are highly effective MHRA-licensed treatments. The best choice depends on individual factors assessed during clinical consultation.
Can I switch from Wegovy to Mounjaro or vice versa?
Yes, patients can switch between Mounjaro vs Wegovy under prescriber guidance, though a washout period may be recommended. Your UK prescriber will determine appropriate starting doses based on your previous treatment response and current tolerability.
How quickly do Mounjaro and Wegovy work?
Most patients notice appetite suppression within 1-2 weeks of starting either Mounjaro or Wegovy, with measurable weight loss typically beginning in weeks 2-4. Maximum efficacy develops over 16-20 weeks as doses are titrated to therapeutic levels.
Do Mounjaro and Wegovy have the same side effects?
The Mounjaro vs Wegovy side effect profiles are similar, with nausea, diarrhoea, and vomiting being most common for both. Mounjaro may cause slightly more gastrointestinal symptoms due to its dual-receptor mechanism, though most patients tolerate both treatments well.
Which is cheaper in the UK, Mounjaro or Wegovy?
Wegovy is more affordable, starting from £124.99 at Cured Pharmacy compared to Mounjaro from £124.99. New patients Save £20 off with code Weightlossnew on either treatment, subject to clinical approval.
Can I get Mounjaro or Wegovy on the NHS?
NHS prescription of Mounjaro vs Wegovy for weight management alone is extremely limited, with most patients accessing treatment through private online pharmacies. NICE guidelines restrict NHS provision to specialist weight management services with strict eligibility criteria.
How long should I take Mounjaro or Wegovy?
Most patients continue Mounjaro or Wegovy for 6-12 months to achieve weight loss goals, with some requiring longer-term maintenance therapy. Treatment duration is individualised based on response, tolerability, and clinical need as assessed by your UK prescriber.
Are Mounjaro and Wegovy safe for long-term use?
Both Mounjaro vs Wegovy have demonstrated acceptable safety profiles in clinical trials extending beyond one year, with ongoing monitoring required. Long-term safety data continues to accumulate, and all patients need regular review by healthcare professionals during treatment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.